Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Mattos, Meghan K.
Sereika, Susan M.
Naples, Jennifer G.
and
Albert, Steven M.
2016.
Differences in Benzodiazepine Receptor Agonist Use in Rural and Urban Older Adults.
Drugs - Real World Outcomes,
Vol. 3,
Issue. 3,
p.
289.
Kleczkowska, Patrycja
Smaga, Irena
Filip, Małgorzata
and
Bujalska-Zadrozny, Magdalena
2016.
Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?.
Neurotoxicity Research,
Vol. 30,
Issue. 4,
p.
698.
Faccini, Marco
Leone, Roberto
Opri, Sibilla
Casari, Rebecca
Resentera, Chiara
Morbioli, Laura
Conforti, Anita
and
Lugoboni, Fabio
2016.
Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases.
Journal of Psychopharmacology,
Vol. 30,
Issue. 10,
p.
1047.
Paille, F.
and
Maheut-Bosser, A.
2016.
Benzodiazépines et personnes âgées.
NPG Neurologie - Psychiatrie - Gériatrie,
Vol. 16,
Issue. 95,
p.
246.
Wolter, Dirk K.
2017.
Suchtpotenzial und andere Risiken von Benzodiazepinen und Z-Drugs im Alter.
SUCHT,
Vol. 63,
Issue. 2,
p.
81.
Verger, Pierre
Cortaredona, Sébastien
Jacqmin-Gadda, Hélène
Tournier, Marie
and
Verdoux, Hélène
2017.
Eight-Year Follow-up of Hypnotic Delivery by Adults Aged 50 and Older from an Insurance Database.
Sleep,
Vol. 40,
Issue. 11,
Huhtaniska, Sanna
Jääskeläinen, Erika
Heikka, Tuomas
Moilanen, Jani S.
Lehtiniemi, Heli
Tohka, Jussi
Manjón, José V.
Coupé, Pierrick
Björnholm, Lassi
Koponen, Hannu
Veijola, Juha
Isohanni, Matti
Kiviniemi, Vesa
Murray, Graham K.
and
Miettunen, Jouko
2017.
Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study.
Psychiatry Research: Neuroimaging,
Vol. 266,
Issue. ,
p.
73.
Khanra, Sourav
2017.
Benzodiazepine misuse: When shall we wake up?.
Asian Journal of Psychiatry,
Vol. 29,
Issue. ,
p.
134.
Tamburin, Stefano
Faccini, Marco
Casari, Rebecca
Federico, Angela
Morbioli, Laura
Franchini, Enrica
Bongiovanni, Luigi Giuseppe
and
Lugoboni, Fabio
2017.
Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence.
Journal of Psychopharmacology,
Vol. 31,
Issue. 10,
p.
1369.
Creupelandt, Hanne
Anthierens, Sibyl
Habraken, Hilde
Declercq, Tom
Sirdifield, Coral
Siriwardena, Aloysius Niroshan
and
Christiaens, Thierry
2017.
Teaching young GPs to cope with psychosocial consultations without prescribing: a durable impact of an e-module on determinants of benzodiazepines prescribing.
BMC Medical Education,
Vol. 17,
Issue. 1,
Fixsen, Alison M.
and
Ridge, Damien
2017.
Stories of Hell and Healing: Internet Users’ Construction of Benzodiazepine Distress and Withdrawal.
Qualitative Health Research,
Vol. 27,
Issue. 13,
p.
2030.
Longo, Dan L.
and
Soyka, Michael
2017.
Treatment of Benzodiazepine Dependence.
New England Journal of Medicine,
Vol. 376,
Issue. 12,
p.
1147.
Steinman, Michael A.
Low, Marcelo
Balicer, Ran D.
and
Shadmi, Efrat
2017.
Epidemic Use of Benzodiazepines among Older Adults in Israel: Epidemiology and Leverage Points for Improvement.
Journal of General Internal Medicine,
Vol. 32,
Issue. 8,
p.
891.
Tamburin, Stefano
Federico, Angela
Faccini, Marco
Casari, Rebecca
Morbioli, Laura
Sartore, Valentina
Mirijello, Antonio
Addolorato, Giovanni
and
Lugoboni, Fabio
2017.
Determinants of Quality of Life in High-Dose Benzodiazepine Misusers.
International Journal of Environmental Research and Public Health,
Vol. 14,
Issue. 1,
p.
38.
Dobrovolsky, Alexander
Ichim, Thomas E.
Ma, Daqing
Kesari, Santosh
and
Bogin, Vladimir
2017.
Xenon in the treatment of panic disorder: an open label study.
Journal of Translational Medicine,
Vol. 15,
Issue. 1,
Mühlig, Stephan
and
Wolter, Dirk K.
2017.
Praxishandbuch Gerontopsychiatrie und -Psychotherapie.
p.
121.
Morgan, Steven G.
and
Weymann, Deirdre
2017.
Patterns, predictors and persistence of chronic sedative use: a population-based observational study of older adults in British Columbia, Canada.
European Journal of Clinical Pharmacology,
Vol. 73,
Issue. 8,
p.
1001.
Ivashchenko, Dmitriy V.
Ryzhykova, Kristina A.
Sozaeva, Zhannet A.
Zastrozhin, Mikhail S.
Grishina, Elena A.
Savchenko, Lyudmila M.
Bryun, Eugeniy A.
and
Sychev, Dmitriy A.
2017.
Pharmacogenetic evaluation of adverse events’ risk in patients with alcohol withdrawal syndrome taking bromdihydrochlorphenylbenzodiazepine: The role of CYP2C19 gene polymorphisms.
World Journal of Personalized Medicine,
Vol. 1,
Issue. 1,
p.
18.
Jacob, Louis
Rapp, Michael A.
and
Kostev, Karel
2017.
Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis.
Therapeutic Advances in Psychopharmacology,
Vol. 7,
Issue. 6-7,
p.
191.
Lee, Xiao-Pen
Shouji, Yukiko
Kumazawa, Takeshi
Hasegawa, Chika
Fujishiro, Masaya
Sato, Junichi
Hasegawa, Iwao
and
Sato, Keizo
2017.
Rapid and highly sensitive analysis of benzodiazepines and tandospirone in human plasma by automated on-line column-switching UFLC-MS/MS.
Legal Medicine,
Vol. 24,
Issue. ,
p.
36.
Comments
No Comments have been published for this article.